export const meta = {
  title: "HYROX Anti Doping Code - Part 17 of 43",
  description: "Part 17 of 43 from HYROX-Anti-Doping-Code.pdf (27 pages total)",
  sourceFile: "HYROX-Anti-Doping-Code.pdf",
  totalPages: 27,
  category: "pdf",
  part: 17,
  totalParts: 43,
  extractedDate: "2025-08-21T23:28:47.254Z"
}

# HYROX Anti Doping Code - Part 17 of 43

*Part 17 of 43 from HYROX-Anti-Doping-Code.pdf (27 pages total)*

7.1 General Pre-adjudication shall be conducted in accordance with this Article 7.
7.1.1 Pre-adjudication designates the process from the time of learning of an Adverse
Analytical Finding or of an Atypical Finding or of any other anti-doping rule violation
or of any violation of a filing failure or missed test up to the conduct of Adjudication
in accordance with the specifications of the International Standard for Results
Management (see wada-ama.org/international-standard-results-management).
7.1.2 HYROX-World shall be responsible for Pre-adjudication and Results Management
concerning Out-of-Competition and In-Competition Testing, including the initial
review. In this respect, HYROX-World bears sole and full responsibility with all
consequences for the procedure and responsibility.
7.1.3 to 7.1.7 [Left blank]
7.2 Initial review and notification in the case of potential anti-doping rule violations
Initial review and notification with respect to potential anti-doping rule violations shall
be carried out in accordance with the International Standard for Results
Management.
7.3 Identification of prior anti-doping rule violations
Before an Athlete or other Person is informed of a potential anti-doping rule violation,
HYROX-World shall be entitled to refer to and contact WADA and other relevant Anti-
Doping Organizations to determine whether any prior anti-doping rule violation
exists.
7.4 Provisional Suspension
7.4.1 Mandatory Provisional Suspension after an Adverse Analytical Finding or Adverse
Analytical Finding of the Athlete Biological Passport
If an Adverse Analytical Finding of the A-Sample or an Adverse Analytical Finding of
the Athlete Biological Passport (after completion of the proceedings to review the
Adverse Analytical Finding of the Athlete Biological Passport) that is due to a
Prohibited Substance that is not a Specified Substance, or due to a Prohibited Method
that is not a Specified Method is found, HYROX-World (see 12.1.3 for the competent
body of HYROX-World) shall declare a Provisional Suspension promptly. A mandatory
Provisional Suspension can be avoided if in HYROX-World ́s opinion (a) the Athlete is
able to explain convincingly that the violation is probably (thus greater than 50%+1)
due to a Contaminated Product, or (b) the violation concerns a Substance of Abuse
and the Athlete proves that reduction of the Ineligibility in accordance with Article
10.2.4.1 is possible. The decision not to revoke the mandatory Provisional Suspension
based on the submission of the Athlete regarding a Contaminated Product cannot be
challenged.
7.4.2 Optional Provisional Suspension due to an Adverse Analytical Finding for Specified
Substances, Specified Methods, Contaminated Products, or other anti-doping rule
violations

HYROX World GmbH | Bahrenfelder Straße 322 | 22765 Hamburg | Germany

Managing Directors: Jörg Christian Toetzke | Moritz Fürste
Amtsgericht (Local Court) Hamburg - HRB 1447 | Ust-Id.No.: DE311191102

---

*Source: HYROX-Anti-Doping-Code.pdf*
*Total Pages: 27*
*Part 17 of 43*
*Extracted on: 2025-08-21*
